[Federal Register: May 8, 2002 (Volume 67, Number 89)]
[Notices]
[Page 30931-30932]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr08my02-118]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Food and Drug Administration
National Institutes of Health
A Public Health Action Plan To Combat Antimicrobial Resistance
(Part I: Domestic Issues): Meeting for Public Comment on the
Antimicrobial Resistance Interagency Task Force Annual Report
The Centers for Disease Control and Prevention (CDC), Food and Drug
Administration (FDA), and National Institutes of Health (NIH) announce
an open meeting concerning antimicrobial resistance.
Name: A Public Health Action Plan to Combat Antimicrobial
Resistance (Part I: Domestic Issues): Meeting for Public Comment on the
Antimicrobial Resistance Interagency Task Force Annual Report.
Time and Date: 10 a.m.-5 p.m., June 26, 2002.
Place: Holiday Inn Select, Versailles Ballroom, 8120 Wisconsin
Avenue, Bethesda, Maryland, 20814. (Toll-Free: 1-877-888-3001; Tel: 1-
301-652-2000; Fax: 1-301-652-4525).
Status: Open to the public, limited only by the space available.
Purpose: To present the first annual report of progress by Federal
agencies in accomplishing activities outlined in A Public Health Action
Plan to Combat Antimicrobial Resistance (Part I: Domestic Issues) and
solicit comments from the public regarding the annual report. The
Action Plan serves as a blueprint for activities of Federal agencies to
address antimicrobial resistance. The focus of the plan is on domestic
issues.
Matters To Be Discussed: The agenda will consist of welcome,
introductory comments, followed by discussion of each focus area in
sequential plenary sessions lasting about 75 minutes each. The four
focus areas are: Surveillance, Prevention and Control, Research, and
Product Development. Session leaders will give a 10 to 15 minute
overview at the beginning of each session, then open the meeting for
general discussion.
Comments and suggestions from the public for Federal agencies
related to each of the focus areas will be taken under advisement by
the Antimicrobial Resistance Interagency Task Force. The agenda does
not include development of consensus positions, guidelines, or
discussions or endorsement of specific commercial products.
The Action Plan, Annual Report, and meeting agenda are available at
http://www.cdc.gov/drugresistance. The public meeting is sponsored by
the CDC, FDA, and NIH in collaboration with seven other Federal
agencies and departments involved in developing and writing A Public
Health Action Plan to Combat Antimicrobial Resistance (Part I: Domestic
Issues).
Agenda items are subject to change as priorities dictate.
Limited time will be available for oral questions, comments, and
suggestions from the public. Depending on the number wishing to
comment, a time limit of three minutes may be imposed. In the interest
of time, visual aids will not be permitted, although written material
may be submitted for subsequent review by the Task Force. Written
comments and suggestions from the public are encouraged and should be
received by the contact person or email listed below prior to the
opening of the meeting or no later than the end of July 2002.
[[Page 30932]]
Persons anticipating attending the meeting are requested to send
written notification by June 22, 2002, including name, organization (if
applicable), address, phone, fax, and e-mail address.
CONTACT PERSON FOR MORE INFORMATION: Vickie Garrett, Antimicrobial
Resistance, Office of the Director, NCID, CDC, Mailstop C-12, 1600
Clifton Road, NE, Atlanta, GA 30333; telephone 404-639-2603; fax 404-
639-4197; or e-mail aractionplan@cdc.gov.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities,
for both the Centers for Disease Control and Prevention and the Agency
for Toxic Substances and Disease Registry.
Dated: April 11, 2002.
Alvin Hall,
Acting Director, Management Analysis and Services Office, Centers for
Disease Control and Prevention.
Dated: April 16, 2002.
Ruth L. Kirschstein,
Acting Director, National Institutes of Health.
Dated: April 26, 2002.
Margaret M. Dotzel,
Associate Commissioner for Policy.
[FR Doc. 02-11361 Filed 5-7-02; 8:45 am]
BILLING CODE 4163-18-P